As far as I am aware, the answer to the original question is a no.
Australia uses evidence based practice. Meaning anything done by a healthcare professional SHOULD always be able to fall back onto research to justify their actions.
Therefore a GP would be taking one hell of a risk by prescribing a drug meant for one use, for another, without the backing of research to suggest its appropriate.
Happy to be proven wrong, but I'm fairly confident its a no, that would defeat the entire purpose of doing all of these studies in the first place if a GP could go "hmmm lets have a go at using Ventolin to cure athletes foot, it might work, lets have a crack"
Application, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.34 |
Change
0.235(1.17%) |
Mkt cap ! $2.607B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $1.559M | 76.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 53 | $20.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.35 | 4 | 3 |
View Market Depth
| Last trade - 14.14pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |